Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

Exogenous Ketosis in a Fed and a Fasted State

Not Applicable

Recruiting

Conditions: Ketosis
Exogenous Ketosis

First Posted Date: 2024-03-20

Last Posted Date: 2024-03-20

Lead Sponsor: University of Oxford

Target Recruit Count: 12

Registration Number: NCT06320522

Locations: 🇬🇧
Oxford Centre for Diabetes, Endocrinology, and Metabolism (OCDEM), Oxford, Oxfordshire, United Kingdom

A Phase 1 Study to Assess an Escalating Dose, Multi-prime Vaccination Schedule of R21/Matrix-M™

Phase 1

Recruiting

Conditions: Malaria,Falciparum

Interventions: Biological: R21/Matrix M™ (Group 1)
Biological: R21/Matrix M™ (Group 3)
Biological: R21/Matrix M™ (Group 2)
Procedure: Fine needle aspiration (FNA)

First Posted Date: 2024-03-20

Last Posted Date: 2025-06-13

Lead Sponsor: University of Oxford

Target Recruit Count: 36

Registration Number: NCT06320535

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Meducine, Churchill Hospital, University of Oxford, Oxford, Oxfordshire, United Kingdom
🇬🇧
University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom

BCG Revaccination Study in Diabetic and Non-Diabetic Adults

Not Applicable

Recruiting

Conditions: Tuberculosis

First Posted Date: 2024-02-07

Last Posted Date: 2024-02-07

Lead Sponsor: University of Oxford

Target Recruit Count: 36

Registration Number: NCT06246851

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom

Postpartum Primaquine in Breast Milk

Phase 4

Completed

Conditions: Postpartum Women

Interventions: Drug: Primaquine

First Posted Date: 2024-01-05

Last Posted Date: 2025-06-10

Lead Sponsor: University of Oxford

Target Recruit Count: 12

Registration Number: NCT06191458

Locations: 🇹🇭
Shoklo Malaria Research Unit (SMRU), Mae Ramat, Tak, Thailand

Hypertension Explored in Long-term Postpartum Follow-up in Later Life

Recruiting

Conditions: Hypertension
Cardiovascular Diseases
Cerebrovascular Disorders
Vascular Diseases

First Posted Date: 2024-01-02

Last Posted Date: 2024-01-02

Lead Sponsor: University of Oxford

Target Recruit Count: 200

Registration Number: NCT06187012

Locations: 🇬🇧
University of Oxford Department of Cardiovascular Medicine, Oxford, United Kingdom

A Study to Compare Two Dosing Regimens for a New Malaria Vaccine

Phase 1

Active, not recruiting

Conditions: Protozoan Infections
Malaria
Infections
Vector Borne Diseases
Parasitic Disease
Malaria,Falciparum

Interventions: Biological: Matrix M with RH5.1

First Posted Date: 2023-11-21

Last Posted Date: 2024-10-04

Lead Sponsor: University of Oxford

Target Recruit Count: 24

Registration Number: NCT06141057

Locations: 🇬🇧
Sheffield Teaching Hospitals, Royal Hallamshire Hospital, Sheffield, United Kingdom

Restore-B: A Trial Comparing Prepectoral Implant-based Breast Reconstruction With and Without Mesh

Not Applicable

Conditions: Breast Cancer
Risk Reduction

First Posted Date: 2023-11-02

Last Posted Date: 2023-11-02

Lead Sponsor: University of Oxford

Target Recruit Count: 40

Registration Number: NCT06112977

Locations: 🇬🇧
Surigcal Intervention Trials Unit (SITU), Nuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, United Kingdom

Ketogenic Diet for Treatment-Resistant Depression: Dietary Interventions for MEntal Health Study (DIME)

Not Applicable

Completed

Conditions: Treatment Resistant Depression
Depression
Mental Disorder
Mental Illness
Depressive Disorder

First Posted Date: 2023-10-19

Last Posted Date: 2025-02-12

Lead Sponsor: University of Oxford

Target Recruit Count: 88

Registration Number: NCT06091163

Locations: 🇬🇧
University of Oxford, Oxford, United Kingdom

Assessment of Safety, Immunogenicity and Efficacy of R21/Matrix-M1 Malaria Vaccine in Healthy WOCBP in Mali

Phase 2

Recruiting

Conditions: Healthy Women of Child Bearing Potential

Interventions: Biological: R21/Matrix-M1
Other: Sterile isotonic (0.9%) normal saline
Biological: Saline and R21/Matrix-M1

First Posted Date: 2023-10-12

Last Posted Date: 2025-04-02

Lead Sponsor: University of Oxford

Target Recruit Count: 330

Registration Number: NCT06080243

Locations: 🇲🇱
Koumantou Study Clinic, Bougouni, Sikasso Region, Mali

Mass Vaccine and Drug Administration, Bangladesh

Phase 4

Recruiting

Conditions: Plasmodium Falciparum Malaria

Interventions: Biological: Study vaccine R21/Matrix-M™
Drug: DHA/piperaquine and a SLD-PQ

First Posted Date: 2023-10-05

Last Posted Date: 2025-02-24

Lead Sponsor: University of Oxford

Target Recruit Count: 10000

Registration Number: NCT06068530

Locations: 🇧🇩
Alikadam Upazila Health Complex, Bāndarban, Bangladesh
🇧🇩
Lama Upazila Health Complex, Lama, Bangladesh

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy